secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeuroPace Inc (NPCE)
CIK:        0001528287
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001528287-24-000019
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroPace Q3 revenue $21.1M (+28% YoY); raises FY2024 guidance to $78-80M
-------------------------------------------------------------------------

- Record quarterly revenue $21.1M vs $16.4M Q3 2023, driven by RNS System sales.
- Net loss narrowed to $5.5M ($0.22 EPS) from $7.3M; operating loss $4.2M vs $6.0M.
- Cash burn reduced to $1.8M from $2.3M; cash & investments $56.8M at quarter end.
- Full-year 2024 revenue guidance raised to $78-80M (19-22% growth); gross margin guided 72-74%.
- Appointed Brett Wingeier VP R&D, Katie Keller VP Marketing, Amy Treadwell VP HR.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1528287/000152828724000019/0001528287-24-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1528287/000152828724000019/npce-20241112.htm
  HTML page:      https://secwatch.observer/filing/0001528287-24-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer